Company: H.V.T. Medical Technologies
A dedicated device for cusp splitting to prevent coronary obstruction post Trans-catheter Aortic Valve Implantation (TAVI). The risk of coronary obstruction is very high (~30%) in Valve-in–valve and TAVI-in-TAVI (~20%). Valve-in-valve: 5% with 50% risk to coronaries.